Papers
11
Total Citations
110
H-Index
6
About
Giovanni Scambia stands at the forefront of gynecologic oncology and minimally invasive surgery, with his most recent body of work cementing his reputation as a leading authority on robotic-assisted surgical systems. Based at an ESGO-accredited tertiary care center, Scambia has dedicated significant effort to rigorously evaluating the clinical utility of robotic platforms across a spectrum of gynecologic conditions, including endometrial cancer, endometriosis, and recurrent ovarian cancer. His contributions span both technical innovation and clinical evidence generation. Notably, his randomized controlled trial comparing robotic-assisted and conventional laparoscopic surgery in obese patients with early endometrial cancer addresses one of the field's most pressing surgical challenges, while his learning curve analyses using CUSUM methodology provide practical guidance for centers adopting new systems such as the Hugo™ RAS platform. Scambia has also pioneered robotic techniques for complex procedures, including totally intracorporeal colorectal anastomosis in recurrent ovarian cancer cases. Collectively accumulating over 100 citations within just two years, his work is rapidly shaping how surgeons worldwide approach robotic gynecologic oncology. His forward-looking reviews integrating artificial intelligence and image-guided surgery further signal his commitment to defining the next generation of surgical care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6Robotic platforms in gynaecological surgery: past, present, and future11 citations · 2024
- 7Robotic staging for early ovarian cancer in 10 steps3 citations · 2024
- 8
- 9
- 10